Navigation Links
Southwest Skin and Cancer Institute Employs Botox for New Indications
Date:9/23/2013

Prescott, AZ (PRWEB) September 24, 2013

Since 2002, Botox has been used to reduce the appearance of fine lines and wrinkles around the brow, forehead, chin, crow’s feet and neck. These creases often create a tired or stressed appearance which can be softened by the use of Botox. With relaxation of the facial muscles, the skin generates new collagen which fills in the creases. But besides the face, Botox has been used to reduce excessive perspiration, which can be embarrassing and result in staining of clothes. Botox has been effective at relaxing tense jaw muscles which cause TMJ or teeth-grinding. Finally, Botox is recognized to reduce the frequency of migraines. Recently, even more uses for Botox have been discovered, revealing how versatile the drug is.

Research by the American Academy of Dermatology, continues to lead to an understanding of how Botox interacts with the blood vessels and nerves. This research is being spurred by the huge potential for future breakthroughs in the treatment of certain inflammatory skin diseases, like psoriasis and eczema, which are typically treated with topical steroids. Steroids can reduce inflammation of skin, however they are a double-edged sword since prolonged use can lead to irreversible thinning of the skin and other side effects. Because of this, dermatologists are constantly seeking alternatives to topical steroid drugs. Botox appears to moderate inflammation in both psoriasis and eczema.

Another use of Botox that has shown effectiveness is for the treatment chronic itching of unknown cause. The sensation of itch is carried by nerve fibers. Since the mechanism of Botox is to interrupt nerve signals from reaching the brain, it is no surprise that Botox can prevent itching in some cases.

According to the Plastic Surgery Institute of Southern Illinois University in 2012, Botox has been shown to combat rheumatic conditions such as Raynaud’s phenomenon, a disorder in which cold temperatures cause painful swelling of the fingertips. When Botox is injected, relief of pain is almost immediate in about 84% of participants. Up to now reliable treatment for Raynaud’s syndrome has not been available.

“I am pleased to have found a novel approach to the treatment of psoriasis, chronic itching and Raynaud’s phenomena that is safe and effective,” comments Robin Fleck, M.D., medical director of Southwest Skin and Cancer Institute in Prescott, Arizona. Dr. Fleck has recently begun to evaluate the drug for these medical conditions in her dermatology practice.

Cosmetic dermatologist, Robin Fleck, M.D., is a double board certified dermatologist and internist, recognized by the American Board of Dermatology and the American Board of Internal Medicine. She is founder and Medical Director of Southwest Skin and Cancer Institute and Body Oasis Laser Aesthetics http://www.rejuvadoc.com. Dr. Fleck is a fellow of the American Society of Laser Medicine and Surgery and the American Academy of Dermatology. Dr. Fleck is also the director of Vein Specialties in Prescott, Arizona and is a member of the American Venous Forum.

Read the full story at http://www.prweb.com/releases/2013/9/prweb10752716.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Southwestern Ear, Nose, and Throat Hearing and Balance Center Welcomes Audiology Externs to Santa Fe
2. Southwest Skin & Cancer Institute Exposes Link between Acne and Diet
3. Dr. Jeffrey Kenkel Appointed as Education Director of Department of Plastic Surgery at UT Southwestern Medical Center
4. Southwestern Ear, Nose & Throat Associates Offers Guidelines On Hearing Loss, Lack of Sleep Affecting Back-to-School Health
5. Elevate Ventures Partners with Southwest Indiana Region Community Stakeholders to Launch Regional Entrepreneurship Action Plan
6. “We Made the Grade” at Southwest General Hospital
7. 911 Signal USA Attends the 2013 Southwest Police Fleet Expo
8. Southwest Health Center Hires New CFO
9. Palm Springs Sizzles at 31st Annual Southwest Dance Expo by Brad Schmett
10. Valley Fever Fungal Infection on Rise in Southwest
11. Southwest Skin & Cancer Institute Celebrates Ten Years of Service to Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/6/2016)... ... 2016 , ... Research has shown that building shame resilience ... and level of relapse. , At the 2016 iaedp Symposium, the ... the critical tasks of the recovery phase and beyond including relapse prevention and ...
(Date:2/5/2016)... ... February 05, 2016 , ... Love is in the ... a variety of colors, assortments and packaging. This staple for Valentine’s Day is a ... location. , For Valentine’s Day, not only are long-stem roses available, but also ...
(Date:2/5/2016)... City, UT (PRWEB) , ... February 05, 2016 , ... ... Whole-Food Nutrition , announced that the much-anticipated feature with author Jahnavi Foster, specialist in ... Humans Amateur TV Network. , Each week, on his weekly Whole-Food Warrior TV show, ...
(Date:2/5/2016)... ... February 05, 2016 , ... The event is being held ... Event Center in Minneapolis, Minn. Triumph Over Parkinson’s will fund nearly $100,000 for research ... Schneiderman’s Furniture, lives with Parkinson’s disease and is the architect of this informative event ...
(Date:2/5/2016)... Santa Rosa, CA (PRWEB) , ... February 05, ... ... are pleased to announce the addition of micro-needling services in their Napa Valley ... appearance. The founders of Plastic Surgery Associates, Dr. Canales and Dr. Furnas, are ...
Breaking Medicine News(10 mins):
(Date:2/4/2016)... 2016 Wegener Polyangiitis - Pipeline Review, ... ,Wegener Polyangiitis - Pipeline Review, H2 2015, provides ... This report provides comprehensive information on the ... analysis at various stages, therapeutics assessment by drug ... (RoA) and molecule type, along with latest updates, ...
(Date:2/4/2016)... -- Omnicell, Inc. (NASDAQ: OMCL ), a leading provider of ... announced results for its fiscal year and fourth quarter ... --> GAAP results: Revenue for the fourth quarter ... 4.1% from the third quarter of 2015, and up ... 2014. Revenue for the year ended December 31, 2015 was ...
(Date:2/4/2016)... 2016  Blueprint Medicines Corporation (NASDAQ: BPMC ... selective investigational kinase medicines for patients with genomically ... board of directors of Lonnel Coats , ... of industry-related experience. Jeffrey Albers ... strong strategic experience developing and commercializing numerous oncology ...
Breaking Medicine Technology: